Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
Year-over-year debt growth rate
Percentile
P31
Within normal range
vs 3Y Ago
-1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -10.87% |
| Q3 2025 | -13.53% |
| Q2 2025 | -11.58% |
| Q1 2025 | -10.10% |
| Q4 2024 | 23.52% |
| Q3 2024 | 29.43% |
| Q2 2024 | 12.82% |
| Q1 2024 | -16.84% |
| Q4 2023 | -10.68% |
| Q3 2023 | -12.57% |
| Q2 2023 | -10.82% |
| Q1 2023 | -9.50% |
| Q4 2022 | 11.16% |
| Q3 2022 | -9.55% |
| Q2 2022 | 51.76% |
| Q1 2022 | -13.12% |
| Q4 2021 | -1.20% |
| Q3 2021 | 10.88% |
| Q2 2021 | -11.45% |
| Q1 2021 | -9.91% |
| Q4 2020 | -8.59% |
| Q3 2020 | 25.26% |
| Q2 2020 | -19.75% |
| Q1 2020 | 3.58% |
| Q4 2019 | -2.09% |
| Q3 2019 | -15.21% |
| Q2 2019 | -15.81% |
| Q1 2019 | 15.60% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -100.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | -100.00% |
| Q3 2016 | 0.41% |
| Q2 2016 | 0.00% |
| Q1 2016 | -100.00% |